1. Home
  2. WWR vs PYPD Comparison

WWR vs PYPD Comparison

Compare WWR & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WWR

Westwater Resources Inc.

HOLD

Current Price

$0.41

Market Cap

82.3M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$3.97

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WWR
PYPD
Founded
1977
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.3M
71.7M
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
WWR
PYPD
Price
$0.41
$3.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$1.92
$12.25
AVG Volume (30 Days)
614.4K
333.3K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$3.06
52 Week High
$3.75
$5.73

Technical Indicators

Market Signals
Indicator
WWR
PYPD
Relative Strength Index (RSI) 34.69 40.96
Support Level N/A $3.50
Resistance Level $0.51 $4.44
Average True Range (ATR) 0.02 0.42
MACD 0.00 -0.15
Stochastic Oscillator 20.63 28.37

Price Performance

Historical Comparison
WWR
PYPD

About WWR Westwater Resources Inc.

Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: